Hyderabad (Telangana) [India], September 12 (ANI): Vaccine manufacturer Indian Immunologicals Limited (IIL) signed a Memorandum of Association (MoA) with the Indian Council of Medical Research (ICMR) for clinical development of Zika vaccine. As per the MoA, the Indian Council of Medical Research (ICMR) will fund the Phase I clinical trial costs, including the costs relating to the conduct, investigations, and monitoring of the clinical trial. The trial will be conducted at the ICMR network sites in India. Speaking on the occasion, Dr K Anand Kumar, Managing Director, Indian Immunologicals Limi…